Skip to main content

ROYCE & ASSOCIATES LP

Position in INVA — Innoviva, Inc.

CIK 906304 New York, NY

Position in INVA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$24,731,738
+$6,334,602 QoQ
Shares Held
1,061,448
+15.3% QoQ
Ownership
1.44%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in INVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ROYCE & ASSOCIATES LP holds $280,717,366 across 29 Biotechnology names. INVA ranks #3 (8.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 INVA
Innoviva, Inc.
This page
1,061,448 $24,731,738

All Filings in INVA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,731,738 1,061,448
2025-12-31 $18,397,136 920,317
2025-09-30 $9,232,784 505,906
2025-06-30 $1,371,182 68,252
2025-03-31 $1,271,348 70,124
2024-12-31 $1,034,493 59,625
2024-09-30 $1,118,203 57,908
2024-06-30 $729,701 44,494
2024-03-31 $1,053,175 69,106
2023-12-31 $1,350,199 84,177
2023-09-30 $1,513,984 116,550
2023-06-30 $1,506,773 118,364
2023-03-31 $1,320,975 117,420
2022-12-31 $1,316,599 99,366
2022-09-30 $942,859 81,211
2022-06-30 $1,155,663 78,297
2022-03-31 $1,557,462 80,489
2021-12-31 $1,569,077 90,961
2021-09-30 $1,443,092 86,361
2021-06-30 $1,143,604 85,280
2021-03-31 $985,193 82,443
2020-12-31 $975,278 78,715
2020-09-30 $800,720 76,624
2020-06-30 $1,060,914 75,888
2020-03-31 $890,020 75,682